Silencing ASF1B in prostate cancer blocked replication and cell cycle arrest and induced apoptosis, while knocking down ASF1B in cervical cancer was linked to proliferation, migration, and antiapoptosis effects [10]. The gene discussed is ASF1B; the disease is prostate carcinoma.